Showing results (1481-1490 of 10,441) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|April 10, 1999
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentrationI F Hoffman, C S Jere, T E Taylor, et al.AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.AIDS (London, England)|April 15, 1999
Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, P Phillips, et al.AIDS (London, England)|April 15, 1999
Nosocomial infections in HIV infected patients. Gruppo HIV e Infezioni OspedaliereN Petrosillo, G Pugliese, E Girardi, et al.AIDS (London, England)|March 9, 2000
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study GroupJ B Hubert, M Burgard, E Dussaix, et al.AIDS (London, England)|March 9, 2000
Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study groupJ P Moatti, M P Carrieri, B Spire, et al.AIDS (London, England)|March 9, 2000
High HIV seroprevalence associated with gonorrhea: New York City Department of Health, sexually transmitted disease clinics, 1990-1997L V Torian, H A Makki, I B Menzies, et al.AIDS (London, England)|March 9, 2000
Estimating the population impact in Australia of improved antiretroviral treatment for HIV infectionM G Law, Y Li, A M McDonald, et al.AIDS (London, England)|August 10, 2000
Neurocognitive and psychological contributions to quality of life in HIV-1-infected womenD M Osowiecki, R A Cohen, K M Morrow, et al.AIDS (London, England)|August 10, 2000
Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural TanzaniaK K Orroth, A Gavyole, J Todd, et al.Pageof 1,045